Cargando…

The use of bioinformatics methods to identify the effects of SARS-CoV-2 and influenza viruses on the regulation of gene expression in patients

BACKGROUND: SARS-CoV-2 infection is a respiratory infectious disease similar to influenza virus infection. Numerous studies have reported similarities and differences in the clinical manifestations, laboratory tests, and mortality between these two infections. However, the genetic effects of coronav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Zhongyi, Ke, Li, Zhao, Qiuyue, Qu, Jiachen, Hu, Yanan, Gao, Han, Peng, Zhiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992716/ https://www.ncbi.nlm.nih.gov/pubmed/36911695 http://dx.doi.org/10.3389/fimmu.2023.1098688

Ejemplares similares

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients
por: Bibert, Stéphanie, et al.
Publicado: (2021)

Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections
por: Hulme, Katina D., et al.
Publicado: (2021)

Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
por: Zhang, Shihan, et al.
Publicado: (2022)

Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model
por: Chen, Yun-Ti, et al.
Publicado: (2022)

Using system biology and bioinformatics to identify the influences of COVID-19 co-infection with influenza virus on COPD
por: Liang, Zihao, et al.
Publicado: (2023)

The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis
por: Huang, Xinwei, et al.
Publicado: (2022)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2
por: Ferrari, Davide, et al.
Publicado: (2022)

Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing
por: Wang, Yanan, et al.
Publicado: (2022)

Comprehensive analysis to identify the influences of SARS-CoV-2 infections to inflammatory bowel disease
por: Zhang, Chengyan, et al.
Publicado: (2023)

Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence
por: Federico, Lorenzo, et al.
Publicado: (2023)

Identifying Risk Factors for Secondary Infection Post-SARS-CoV-2 Infection in Patients With Severe and Critical COVID-19
por: Guo, Mingquan, et al.
Publicado: (2021)

Phylogenomics and bioinformatics of SARS-CoV
por: Liò, Pietro, et al.
Publicado: (2004)

Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
por: Escudero-Pérez, Beatriz, et al.
Publicado: (2023)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020)

SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus
por: Alkayyal, Almohanad A., et al.
Publicado: (2023)

The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom
por: Wu, Jiajing, et al.
Publicado: (2021)

A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
por: Han, Xiaojian, et al.
Publicado: (2021)

Novel neutralizing chicken IgY antibodies targeting 17 potent conserved peptides identified by SARS-CoV-2 proteome microarray, and future prospects
por: Li, Jin, et al.
Publicado: (2022)

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches
por: Hoque, M. Nazmul, et al.
Publicado: (2022)

Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
por: Li, Shufen, et al.
Publicado: (2021)

Cannabidiol and SARS-CoV-2 Infection
por: Vallée, Alexandre
Publicado: (2022)

Integrated bioinformatics to identify potential key biomarkers for COVID-19-related chronic urticaria
por: Zhang, Teng, et al.
Publicado: (2022)

Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses
por: Sun, Xiaoming, et al.
Publicado: (2022)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

The impact of CoronaVac on the neutralization breadth and magnitude of the antibody response to SARS-CoV-2 viruses
por: Zhang, Lu, et al.
Publicado: (2022)

Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses
por: Cao, Yingying, et al.
Publicado: (2021)

Tropism of SARS-CoV-2, SARS-CoV, and Influenza Virus in Canine Tissue Explants
por: Bui, Christine H T, et al.
Publicado: (2021)

The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis
por: Wang, Kai, et al.
Publicado: (2022)

Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
por: Li, Hu, et al.
Publicado: (2022)

Coinfection with influenza A virus enhances SARS-CoV-2 infectivity
por: Bai, Lei, et al.
Publicado: (2021)

Identification of immune-related endoplasmic reticulum stress genes in sepsis using bioinformatics and machine learning
por: Gong, Ting, et al.
Publicado: (2022)

SARS-CoV-2 and influenza virus co-infection
por: Cuadrado-Payán, Elena, et al.
Publicado: (2020)

Antigenic characterization of influenza and SARS-CoV-2 viruses
por: Wang, Yang, et al.
Publicado: (2021)

Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity
por: Desikan, Rajat, et al.
Publicado: (2022)

SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity
por: Liu, Haolin, et al.
Publicado: (2022)

Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2
por: Pettini, Elena, et al.
Publicado: (2022)

Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay
por: Bai, Xiaoming, et al.
Publicado: (2022)

Immunomodulatory Drugs in the Management of SARS-CoV-2
por: Burrage, Daniel R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3jbcglem3tltf004a70u9ll20f